Market Tracker

01/17 3:34am ET

TherapeuticsMD Inc (NASDAQ:TXMD)

6.21
Delayed Data
As of Jan 16
 +0.06 / +0.98%
Today’s Change
3.50
Today|||52-Week Range
8.30
+2.81%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close6.15
Today’s open6.13
Day’s range6.13 - 6.27
Volume1,639,881
Average volume (3 months)3,067,183
Market cap$1.3B
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book9.49

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-4.50-7.95%
ESPREsperion Therapeutic...-1.35-1.84%
BHVNBiohaven Pharmaceuti...+0.13+0.49%
FWPForward Pharma A/S+0.04+0.91%
Data as of 4:02pm ET, 01/16/2018

Financials

Next reporting dateFebruary 22, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts